Loading…
This event has ended. View the official site or create your own event → Check it out
This event has ended. Create your own

For Campus Prearrival Information <click here>
For a PDF of the 2015 Program Materials <click here>
For ALL Abstracts [1-220] in sequential order <click here>
For ALL Authors of the Lecture and Poster Presentations <click here>


View analytic
Tuesday, August 25 • 4:00pm - 4:20pm
[0069] Fragment-Based Approach Toward Lactate Dehydrogenase A (LDHA) Inhibitors

Sign up or log in to save this to your schedule and see who's attending!

Limited Capacity seats available

A fragment based approach was used to identify a unique series of LDHA inhibitors with good ligand efficiencies.  Subsequent optimization delivered a novel lead series with LDHA cellular activity of 10 μM, selectivity against LDHB, and good physicochemical properties.  The overall strategy of identification and optimization, lessons learned, and some guiding principles of the FBDD effort will be presented in the context of the discovery of a fragment-derived lead series for the inhibition of LDHA.

 “All studies were conducted in accordance with the GSK Policy on the Care, Welfare and Treatment of Laboratory Animals and were reviewed the Institutional Animal Care and Use Committee either at GSK or by the ethical review process at the institution where the work was performed.”


ST Lecturers
avatar for Beth Knapp-Reed

Beth Knapp-Reed

Investigator, GlaxoSmithKline
Investigator GlaxoSmithKline



Tuesday August 25, 2015 4:00pm - 4:20pm
MCC Theater